People · Operator
Named in public records as an officer, director or promoter · active 2010–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kalidex Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $8.5M | $255.5M | 2010 |
Shelley (Vernon) Chu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shelley (Vernon) Chu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dennis (Vernon) Podlesak | 1 | 1 |
| Brent (Vernon) Ahrens | 1 | 1 |
| Gary (Vernon) Patou | 1 | 1 |
| Patrick (Vernon) Heron | 1 | 1 |
| Yigong (James) Ge | 1 | 1 |
| Ron (Vernon) Hunt | 1 | 1 |
| Chun (Vernon) Jiang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.